Serial Number 85743900
602

Registration Progress

Application Filed
Oct 2, 2012
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

Basic Information

Serial Number
85743900
Filing Date
October 2, 2012
Abandonment Date
August 13, 2013
Drawing Code
2000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 9, 2013
Classes
005

Rights Holder

Proteus Digital Health, Inc.

16
Address
2600 Bridge Parkway
Redwood City, CA 94065

Ownership History

Proteus Digital Health, Inc.

Original Applicant
16
Redwood City, CA

Legal Representation

Attorney
Michelle Hon Donovan

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Sep 9, 2013 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 9, 2013 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Feb 11, 2013 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 11, 2013 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 11, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 18, 2013 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 18, 2013 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 10, 2012 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Oct 9, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 5, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Ingestible medications and pharmaceuticals, namely, diagnostic and therapeutic preparations for medical purposes both prescription and over-the-counter, for use in connection with humans and animals, to gather data on patient status and condition, to monitor patient condition, patient adherence to treatment regimens, efficacy of treatment, and to enable personalized therapy for the purpose of maximizing patient outcome in the diagnosis, therapeutic treatment, and management of cancers, chronic pain, skin disease, diseases of the ear, nose, and throat, infectious disease, psychiatric disorders, and diseases of the cardiovascular, respiratory, metabolic, immune, central nervous, endocrine, glandular, musculoskeletal, digestive, excretory, and reproductive systems
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a pill design.
Color Claim
The color(s) red is/are claimed as a feature of the mark.

Classification

International Classes
005